Ortho Clinical Diagnostics Holdings plc (OCDX)

NASDAQ: OCDX · IEX Real-Time Price · USD
17.55
-0.18 (-1.02%)
May 25, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Feb - Jan.
Year20212020201920182017
Revenue
2,042.81,766.21,801.51,787.31,781.7
Revenue Growth (YoY)
15.66%-1.96%0.79%0.31%-
Cost of Revenue
1,006.8908.2922.4930.5897.7
Gross Profit
1,036858879.1856.8884
Selling, General & Admin
555489.6515.1491.6499.8
Research & Development
126.2112.99898.796.4
Other Operating Expenses
180.9167.2180.5200252.5
Operating Expenses
862.1769.7793.6790.3848.7
Operating Income
173.988.385.566.535.3
Interest Expense / Income
146198.2231.4235.6239.8
Other Expense / Income
53.9115.434.948.5-190.2
Pretax Income
-26-225.3-180.8-217.6-14.3
Income Tax
28.3-13.4-23.931.2102
Net Income
-54.3-211.9-156.9-248.8-116.3
Net Income Common
-54.3-211.9-156.9-248.8-116.3
Shares Outstanding (Basic)
22814614614591
Shares Outstanding (Diluted)
22814614614591
Shares Change
55.98%0.55%0.28%59.63%-
EPS (Basic)
-0.24-1.45-1.08-1.72-1.28
EPS (Diluted)
-0.24-1.45-1.08-1.72-1.28
Free Cash Flow Per Share
1.000.010.53-0.07-0.26
Gross Margin
50.71%48.58%48.80%47.94%49.62%
Operating Margin
8.51%5.00%4.75%3.72%1.98%
Profit Margin
-2.66%-12.00%-8.71%-13.92%-6.53%
Free Cash Flow Margin
11.17%0.11%4.26%-0.54%-1.32%
Effective Tax Rate
-108.85%5.95%13.22%-14.34%-713.29%
EBITDA
448.1298.8378.1350.2558.8
EBITDA Margin
21.94%16.92%20.99%19.59%31.36%
EBIT
120-27.150.618225.5
EBIT Margin
5.87%-1.53%2.81%1.01%12.66%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).